SCHEMBL2437366

SCHEMBL2437366

NC(=O)C1(Cc2cc3ccccc3[nH]c2=O)CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 7/20 0.48
NPSR1 Q6W5P4 2/20 0.46
MAPK1 P28482 2/20 0.46
TSHR P16473 4/20 0.46
HSD17B10 Q99714 2/20 0.46
APAF1 O14727 1/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 1/20 0.46
IL4I1 Q96RQ9 3/20 0.44
TP53 P04637 1/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
HPGD P15428 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14732041 0.73 NPSR1 (0.47) NPSR1
SCHEMBL2432421 0.72 KDM4E (0.43) ALDH1A1KDM4ENPSR1TSHRHSD17B10
SCHEMBL2432424 0.72 DAO (0.41) ALDH1A1KDM4ENPSR1MAPK1TSHR
SCHEMBL31184774 0.70 FLT3 (0.42) ALDH1A1KDM4EMAPK1HSD17B10LMNA
SCHEMBL6402311 0.70 DAO (0.59) ALDH1A1KDM4ENPSR1MAPK1TSHR
SCHEMBL17618004 0.70 KDM4E (0.58) ALDH1A1KDM4ENPSR1MAPK1TSHR
SCHEMBL5473260 0.69 KDM4E (0.58) ALDH1A1KDM4ENPSR1MAPK1TSHR
Bicarbonate SCHEMBL6993932 0.69 MAPK1 (0.61) ALDH1A1KDM4ENPSR1MAPK1TSHR
SCHEMBL30434363 0.69 MAPK1 (0.61) ALDH1A1KDM4ENPSR1MAPK1TSHR
SCHEMBL5678790 0.69 MAPK1 (0.61) ALDH1A1KDM4ENPSR1MAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110212946-A1 Quinolone Neuropeptide S Receptor Antagonists MERCK SHARP & DOHME LLC 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212946-A1 Quinolone Neuropeptide S Receptor Antagonists NPSR1, NPY1R, NPY2R ALDH1A1 4731/4885KDM4E 4352/4885NPSR1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.